Onspira Therapeutics, Inc. — Form D/A
Onspira Therapeutics, Inc. of WAYNE, PA, a company, filed a Form D amendment with the SEC on 2019-06-25. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-06-25
- Form: D/A
- Accession: 0001709961-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.9M
- Amount sold: $1.9M
- Minimum investment: $4K
- Investors: 30
- Date of first sale: 2017-06-16
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-289166
Issuer
- Name: Onspira Therapeutics, Inc.
- CIK: 0001709961
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 640 LEE ROAD, SUITE 117, WAYNE, PA, 19087
- Phone: 484-318-2988
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Paul Barone | Director | Delray Beach, FL |
| Roy Levitt | Director | Delray Beach, FL |
| Brian Lortie | Director | Wayne, PA |
| Stephen Tullman | Director | Malvern, PA |
| Paul Barone | Executive Officer | Delray Beach, FL |
| Douglas Gessl | Executive Officer | Wayne, PA |
| Roy Levitt | Executive Officer | Delray Beach, FL |
| Brian Lortie | Executive Officer | Wayne, PA |
| Stephen Tullman | Executive Officer | Malvern, PA |
Other filings by this issuer (2)
More